Drug Trial Radar · NCT01713426
A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment
Last checked: Nov 20, 2026Latest source record: Apr 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
568
Actual
Start
Jul 11, 2012
Primary completion
Sep 26, 2013
Study completion Sep 26, 2013
Sponsor
- Lead sponsor
- Astellas Pharma Europe Ltd.Astellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Oct 24, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is comparing the efficacy and tolerability of Qutenza with that of pregabalin in patients suffering from peripheral neuropathic pain. Treatment allocation will be to one of these treatments and the duration of the study will be about 10 weeks (assuming that from screening to treatment allocation takes 2 weeks). Participants will be asked to complete questionnaires about various aspects relating to their condition throughout the study. This study will include subjects suffering from Postherpetic Neuralgia, Peripheral Nerve Injury or Non Diabetic peripheral polyneuropathy.
Conditions
- Non-diabetic Painful Peripheral Polyneuropathy
- Postherpetic Neuralgia (PHN)
- Peripheral Nerve Injury (PNI)
Interventions
QutenzaDrug
Cutaneous patch
PregabalinDrug
Oral capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects in each arm who achieve at least 30% decrease in the "average pain for the past 24 hours" Numeric Pain Rating Scale (NPRS) score from baseline to week 8Time frame: Baseline and week 8
Locations
98 sites in 22 countries. Site status is shown where the registry gives one.
Site 101 Medical Union 2
Yerevan, Armenia
Site 102 Medical Center Erebuni
Yerevan, Armenia
Site 103 Scientific research Institute of physiotherapy
Yerevan, Armenia
Site 104 Medical Center "Surb Nerses Mets"
Yerevan, Armenia
Site 116 Krankenhaus der Barmherzigen B
Graz, Austria
Site 111 AKH Universitatsklinik
Vienna, Austria
Site 112 Wilhelminenspital
Vienna, Austria
Site 114 Klinikum Klagenfurt Worthersee
Klagenfurt, Carynthia, Austria
Site 115 Medical University Innsbruck
Innsbruck, Tyrol, Austria
Site 121 Vitebsk Regional Clinical Hospital # 1
Vitebsk, Belarus
Site 131 UZ Brussels
Brussels, Belgium
Site 138 Cliniques Universitaires Saint
Brussels, Belgium
Site 134 Grand Hospital de Charleroi
Charleroi, Belgium
Site 137 Univ. Ziekenhuis Antwerpen
Edegem, Belgium
Site 132 Ziekenhuis Oost-Limburg
Genk, Belgium
Site 136 UZ Pellenberg
Pellenberg, Belgium
Site 133 Heilig Hart Ziekenhuis
Roeselare, Belgium
Site 142 UMHAT - Pleven
Pleven, Bulgaria
Site 141 Centre for Mental Health
Rousse, Bulgaria
Site 144 Tokuda Hospital Sofia
Sofia, Bulgaria
Site 146 MHAT Alexandrovska Hospital
Sofia, Bulgaria
Site 147 MHAT Sv. Ivan Rilski
Sofia, Bulgaria
Site 145 Military Medical Academy
Sofia, Bulgaria
Site 151 Fakultni nemocnice Plzen
Pilsen, Czechia
Site 153 Klinika anesteziologie
Prague, Czechia
Site 163 ORTON Invalidisaatio
Helsinki, Finland
Site 161 Finnmedi OY
Tampere, Finland
Site 162 Vassa Central Hospital
Vaasa, Finland
Site 171 Hospital Ambroise Pare
Boulogne-Billancourt, France
Site 174 Hopital Neurologique Pierre W
Bron, France
Site 177 Hospital Roger Salengro CHRU
Lille, France
Site 175 CHU Caremeau
Nîmes, France
Site 172 Hospital Saint Antoine
Paris, France
Site 173 CHU Hopital Nord
Saint-Etienne, France
Site 176 CH Regional de Valence
Valence, France
Site 200 Prax S.Wolf u.B.Schütz Pal.med
Cottbus, Germany
Site 192 Universitätsklinikum Giessen
Giessen, Germany
Site 193 Universitätsklinikum Münster
Münster, Germany
Site 194 Schmerz Palliativznt Wiesbaden
Wiesbaden, Germany
Site 197 Universitätsklinikum Würzburg
Würzburg, Germany
Showing 40 of 98 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.